Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Picci

Showing results (241-250 of 289) with videos related to

Pageof 29
Sort By:
Acta Oncologica (Stockholm, Sweden)|May 8, 1998
Neoadjuvant chemotherapy for extremity osteosarcoma--preliminary results of the Rizzoli's 4th studyG Bacci, S Ferrari, M Mercuri, et al.
Histology and Histopathology|March 17, 2004
Amplification of CDK4, MDM2, SAS and GLI genes in leiomyosarcoma, alveolar and embryonal rhabdomyosarcomaP Ragazzini, G Gamberi, L Pazzaglia, et al.
Cancer Genetics and Cytogenetics|October 20, 1999
Clinical correlations of genetic changes by comparative genomic hybridization in Ewing sarcoma and related tumorsM Tarkkanen, S Kiuru-Kuhlefelt, C Blomqvist, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|March 10, 2001
A comparison of methods of loco-regional chemotherapy combined with systemic chemotherapy as neo-adjuvant treatment of osteosarcoma of the extremityG Bacci, S Ferrari, A Tienghi, et al.
Bone|March 10, 2000
Reversal of malignant phenotype in human osteosarcoma cells transduced with the alkaline phosphatase geneM C Manara, N Baldini, M Serra, et al.
Histology and Histopathology|May 25, 2007
Altered expression of urokinase-type plasminogen activator and plasminogen activator inhibitor in high-risk soft tissue sarcomasM S Benassi, F Ponticelli, E Azzoni, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 16, 2001
Metalloproteinase expression and prognosis in soft tissue sarcomasM S Benassi, G Gamberi, G Magagnoli, et al.
Journal of Chemotherapy (Florence, Italy)|May 23, 2002
High dose ifosfamide in combination with high dose methotrexate, adriamycin and cisplatin in the neoadjuvant treatment of extremity osteosarcoma: preliminary results of an Italian Sarcoma Group/Scandinavian Sarcoma Group pilot studyG Bacci, S Ferrari, A Longhi, et al.
Cancer Research|October 4, 2000
CD99 engagement: an effective therapeutic strategy for Ewing tumorsK Scotlandi, N Baldini, V Cerisano, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 18, 2003
Analysis of dihydrofolate reductase and reduced folate carrier gene status in relation to methotrexate resistance in osteosarcoma cellsM Serra, G Reverter-Branchat, D Maurici, et al.
Pageof 29

Showing results (241-250 of 289) with videos related to

Sort By:
Pageof 29
Acta Oncologica (Stockholm, Sweden)|May 8, 1998
Neoadjuvant chemotherapy for extremity osteosarcoma--preliminary results of the Rizzoli's 4th studyG Bacci, S Ferrari, M Mercuri, et al.
Histology and Histopathology|March 17, 2004
Amplification of CDK4, MDM2, SAS and GLI genes in leiomyosarcoma, alveolar and embryonal rhabdomyosarcomaP Ragazzini, G Gamberi, L Pazzaglia, et al.
Cancer Genetics and Cytogenetics|October 20, 1999
Clinical correlations of genetic changes by comparative genomic hybridization in Ewing sarcoma and related tumorsM Tarkkanen, S Kiuru-Kuhlefelt, C Blomqvist, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|March 10, 2001
A comparison of methods of loco-regional chemotherapy combined with systemic chemotherapy as neo-adjuvant treatment of osteosarcoma of the extremityG Bacci, S Ferrari, A Tienghi, et al.
Bone|March 10, 2000
Reversal of malignant phenotype in human osteosarcoma cells transduced with the alkaline phosphatase geneM C Manara, N Baldini, M Serra, et al.
Histology and Histopathology|May 25, 2007
Altered expression of urokinase-type plasminogen activator and plasminogen activator inhibitor in high-risk soft tissue sarcomasM S Benassi, F Ponticelli, E Azzoni, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 16, 2001
Metalloproteinase expression and prognosis in soft tissue sarcomasM S Benassi, G Gamberi, G Magagnoli, et al.
Journal of Chemotherapy (Florence, Italy)|May 23, 2002
High dose ifosfamide in combination with high dose methotrexate, adriamycin and cisplatin in the neoadjuvant treatment of extremity osteosarcoma: preliminary results of an Italian Sarcoma Group/Scandinavian Sarcoma Group pilot studyG Bacci, S Ferrari, A Longhi, et al.
Cancer Research|October 4, 2000
CD99 engagement: an effective therapeutic strategy for Ewing tumorsK Scotlandi, N Baldini, V Cerisano, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 18, 2003
Analysis of dihydrofolate reductase and reduced folate carrier gene status in relation to methotrexate resistance in osteosarcoma cellsM Serra, G Reverter-Branchat, D Maurici, et al.
Pageof 29